Adalimumab weekly vs placebo
Treatment discontinuation · participants with hidradenitis suppurativa
Adalimumab weekly showed no clear difference in frequency of treatment discontinuation compared with placebo (moderate certainty).
1 finding from 1 review
- RR 5 [0.25, 101.63]1 study · 102 participantsModerate